Neoleish: Zendal Group launches groundbreaking vaccine for animal mammals against leishmaniasis
Neoleish, developed by the Petia subsidiary together with the Higher Council for Scientific Research, is the first for animal mammals and the second in the world with this technology. Petia Vet Health, a subsidiary of the Zendal group, launches the first vaccine for animal mammals based on Recombinant DNA to face the leishmaniasis caninaa parasite … Read more